Skip to main content
. Author manuscript; available in PMC: 2016 Mar 14.
Published in final edited form as: Life Sci. 2014 Dec 11;122:1–7. doi: 10.1016/j.lfs.2014.12.001

Figure 3. MyD88 signaling pathway is decreased in SHR after anti-TLR4 treatment.

Figure 3

(A) MyD88 and (B) TRIF protein expression in mesenteric resistance arteries from IgG- (white bars) and anti-TLR4-treated (black bars) SHR, On top, representative western blot images of MyD88 (A) and TRIF (B) protein expression. Bar graphs show the relative expression of proteins after normalization to β-actin. Each bar represents the mean ± SEM, n = 5–6. *P < 0.05. Statistical test: Student’s t test.